Phase 2 and 3 Clinical Trials
Accelerate Late-Stage Clinical Trials With a Configurable Platform Built for Global Scale
Phase 2 and Phase 3 trials generate the evidence that determines whether therapies move toward approval. As studies expand across countries, sites, participants, and endpoints, operational complexity increases significantly. THREAD helps sponsors and CROs simplify execution with a single configurable platform designed to support global, hybrid, and decentralized clinical trials while reducing burden for participants, sites, and study teams.
Built for the Most Demanding Clinical Trials
Whether you're evaluating efficacy in Phase 2 or generating pivotal evidence in Phase 3, THREAD provides one configurable platform to manage every aspect of participant data collection and engagement.
Our no-code platform helps teams: • Launch studies faster with configurable workflows • Reduce protocol amendment effort through flexible study configuration • Improve participant compliance and retention • Support hybrid and decentralized study designs • Capture high-quality data across every visit and participant interaction • Scale confidently across global studies, countries, and languages
Expert Consulting for Phase 2 & Phase 3 Success
Successful Phase 2 and Phase 3 trials require both the right technology and the right expertise. THREAD's consulting team works alongside sponsors and CROs to optimize study design, participant workflows, protocol execution, and platform configuration, helping reduce operational risk, simplify complex studies, and accelerate study startup.
Our experts also provide guidance on patient-centered study design, COA strategy, eCOA implementation, participant engagement, and workflow optimization to improve recruitment, retention, and data quality. Combined with our configurable no-code platform, THREAD helps teams execute more efficiently while delivering high-quality endpoint data with confidence.
